Drug
Zp7570
Zp7570: highest development phase Phase 1, developed by Zealand Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP7570 NCT04612517 | Phase 1 | Healthy |
| ZP7570 NCT06000891 | Phase 1 | Safety and Tolerability |
Latest
No recent events.
Follow Zp7570 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.